0000899243-21-021981.txt : 20210604 0000899243-21-021981.hdr.sgml : 20210604 20210604142938 ACCESSION NUMBER: 0000899243-21-021981 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210602 FILED AS OF DATE: 20210604 DATE AS OF CHANGE: 20210604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brandenberger Ralph CENTRAL INDEX KEY: 0001853197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39370 FILM NUMBER: 21996003 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 102 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nkarta, Inc. CENTRAL INDEX KEY: 0001787400 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474515206 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-582-4923 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 102 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-02 0 0001787400 Nkarta, Inc. NKTX 0001853197 Brandenberger Ralph C/O NKARTA, INC. 6000 SHORELINE COURT, SUITE 102 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 See Remarks Common Stock 2021-06-02 4 M 0 340 0.41 A 340 D Common Stock 2021-06-02 4 M 0 405 4.77 A 745 D Common Stock 2021-06-02 4 M 0 1358 3.89 A 2103 D Common Stock 2021-06-02 4 M 0 2037 3.89 A 4140 D Common Stock 2021-06-02 4 S 0 4140 24.50 D 0 D Stock Option (right to buy) 0.41 2021-06-02 4 M 0 340 0.00 D 2028-07-18 Common Stock 340 8387 D Stock Option (right to buy) 4.77 2021-06-02 4 M 0 405 0.00 D 2029-05-10 Common Stock 405 10000 D Stock Option (right to buy) 3.89 2021-06-02 4 M 0 1358 0.00 D 2029-09-05 Common Stock 1358 33500 D Stock Option (right to buy) 3.89 2021-06-02 4 M 0 2037 0.00 D 2029-09-05 Common Stock 2037 50250 D The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date. The option is vested and exercisable as to 6,498 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on April 2, 2022. The option is vested and exercisable as to 5,721 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on December 6, 2022. The option is vested and exercisable as to 5,583 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on July 1, 2024. The option is vested and exercisable as to 18,561 shares, and the remaining shares will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023. Sr. VP, Technical Operations /s/ Alicia Hager, as Attorney-in-Fact 2021-06-04